Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus...

FDA Drug Recall #D-1085-2014 - Class II, December 9, 2013

Recall Summary

Recall Number D-1085-2014
Classification Class II - Moderate risk
Date Initiated December 9, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Actavis Inc
Location Parsippany, NJ
Product Type Drugs
Quantity 99 cartons

Product Description

Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial (NDC 52544-154-02) plus MIXJECT Single-Dose Delivery System containing 2 mL Sterile Water for Injection, USP per carton (NDC 52544-188-76), 11.25 mg, Rx Only, Dist. By: Watson Pharma, Inc., Morristown, NJ 07962, Mfd. by: Debio RP, CH-1920 Martigny, Switzerland.

Reason for Recall

Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot #: 13J081, Exp 05/15

Other Recalls from Actavis Inc

Recall # Classification Product Date
D-0514-2017 Class III Levofloxacin Ophthalmic Solution, 0.5%, Sterile... Feb 7, 2017
D-0476-2017 Class II Glipizide extended-release tablets, 2.5mg, 30-c... Jan 30, 2017
D-0439-2017 Class III Albuterol Sulfate Inhalation Solution, USP, 0.0... Jan 12, 2017
D-1471-2016 Class III Acetasol HC (hydrocortisone and acetic acid oti... Aug 2, 2016
D-1472-2016 Class III Hydrocortisone and acetic acid otic solution, R... Aug 2, 2016

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.